Role of SFRP5 in Non-Small Cell Lung Cancer and Its Correlation with SUV of 18F-FDG PET-CT

被引:0
|
作者
Zhang, Na [1 ]
Bai, Tian [1 ]
Jiang, Yunfei [2 ]
Zhu, Kun [3 ]
Yao, Lan [4 ]
Ji, Jia [5 ]
Huang, Qicheng [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Radiog Imaging Ctr, Qiqihar, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Resp Dept, Qiqihar, Peoples R China
[3] Qiqihar Med Univ, Affiliated Hosp 3, Cardiothorac Surg Dept, Qiqihar, Peoples R China
[4] Qiqihar Med Univ, Affiliated Hosp 3, Nucl Med Dept, Qiqihar, Peoples R China
[5] Qiqihar Med Univ, Affiliated Hosp 3, Stomatol Dept, Qiqihar, Peoples R China
关键词
SFRP5; non-small cell lung cancer; 18F-FDG PET-CT; cell proliferation; cell metastasis; WNT; EXPRESSION; MUTATION; MARKERS;
D O I
10.1080/08941939.2024.2381722
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: This study aimed to evaluate the relationship between secreted frizzled-related protein 5 (SFRP5) expression and fluorine 18-fluoro-deoxyglucose (18 F-FDG) uptake imaged with positron emission tomography/tomography (PET/CT) in patients with non-small cell lung cancer (NSCLC). In addition, we sought to elucidate the potential role and mechanism of action of SFRP5 in NSCLC.Materials and methods: The maximum standardized uptake value (SUVmax) of the lesions was calculated. SFRP5 expression was analyzed using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The correlation between SFRP5 expression and SUVmax was evaluated using Pearson's correlation analysis. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, wound healing, and transwell assays were used to analyze cell viability, apoptosis, migration, and invasion, respectively.Results and conclusion: The results indicated that the SUVmax was higher in patients with NSCLC than that in healthy volunteers. Moreover, SFRP5 expression was lower in tissues from the four types of NSCLC than that in the adjacent normal tissues. SUVmax negatively correlated with SFRP5 expression in the four types of NSCLC. In addition, up-regulation of SFRP5 decreased the viability, migration, and invasion abilities, and increased apoptosis of NSCLC cells. Furthermore, SFRP5 inhibited the Wnt/beta-catenin pathway in NSCLC cells. In conclusion, SFRP5 modulates the biological behaviors of NSCLC through Wnt/beta-catenin pathway.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Correlation of SUV on 18F-FDG PET Uptake with polymorphonuclear in Non-small Cell Lung Cancer
    Simo, M.
    Mestre-Fusco, A.
    Pijoan, L.
    Baro, T.
    Casado, B.
    Trampal, C.
    Rodriguez, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S294 - S294
  • [2] Role of 18F-FDG PET/CT in radiotherapy planning for patients with non-small cell lung cancer
    Garcia-Talavera, P.
    Matias-Perez, A.
    Cigarrol, C.
    Gomez-Caminero, F.
    Perez-Romasanta, L. A.
    Martin, M. E.
    Martin, E.
    Perez, B.
    Tamayo, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S485 - S485
  • [3] Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    Julian Kirchner
    Lino M. Sawicki
    Felix Nensa
    Benedikt M. Schaarschmidt
    Henning Reis
    Marc Ingenwerth
    Simon Bogner
    Clemens Aigner
    Christian Buchbender
    Lale Umutlu
    Gerald Antoch
    Ken Herrmann
    Philipp Heusch
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 437 - 445
  • [4] Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
    Hicks, Rodney J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 31S - 42S
  • [5] Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    Kirchner, J.
    Sawicki, L. M.
    Schaarschmidt, B. M.
    Umutlu, L.
    Herrmann, K.
    Buchbender, C.
    Antoch, G.
    Heusch, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S502 - S502
  • [6] Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    Kirchner, Julian
    Sawicki, Lino M.
    Nensa, Felix
    Schaarschmidt, Benedikt M.
    Reis, Henning
    Ingenwerth, Marc
    Bogner, Simon
    Aigner, Clemens
    Buchbender, Christian
    Umutlu, Lale
    Antoch, Gerald
    Herrmann, Ken
    Heusch, Philipp
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (02) : 437 - 445
  • [7] A Rare Case of Non-Small Cell Lung Cancer Metastasizing to the Pituitary Gland Detection With 18F-FDG PET-CT
    Agarwal, Krishan Kant
    Sharma, Punit
    Singla, Suhas
    Suman, Sudhir K. C.
    Bal, Chandrasekhar
    Kumar, Rakesh
    [J]. CLINICAL NUCLEAR MEDICINE, 2014, 39 (05) : E318 - E319
  • [8] The added value of 18F-FDG PET/CT in staging non-small cell lung cancer
    Sheha, Aliaa S.
    Elia, Remon Zaher
    Ghoneim, Nada Mohammed Farid Hassan
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01):
  • [9] Role of 18F-FDG PET/CT and sarcopenia in untreated non-small cell lung cancer with advanced stage
    Yuan, Hui
    Tan, Xiaoyue
    Sun, Xiaolin
    He, Li
    Li, Dongjiang
    Jiang, Lei
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2023, 41 (05) : 521 - 530
  • [10] Impact of 18F-FDG PET/CT in the Treatment of Patients With Non-Small Cell Lung Cancer
    Taus, Alvaro
    Aguilo, Rafael
    Curull, Victor
    Suarez-Pinera, Marina
    Rodriguez-Fuster, Alberto
    Rodriguez de Dios, Nuria
    Pijuan, Lara
    Zuccarino, Flavio
    Vollmer, Ivan
    Sanchez-Font, Albert
    Belda-Sanchis, Jose
    Arriola, Edurne
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2014, 50 (03): : 99 - 104